Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape 

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/1/2026

1. AMZN
2. RBLX
3. AAPL
4. RDDT
5. COIN
6. NBIX
7. DXCM
8. GDDY
9. WU
10. FND

Go back to Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape 
Amarin Corp Plc (NASDAQ: AMRN) Delayed: 14.26 +0.03 (0.21%)
Previous Close $14.23    52 Week High $3.65 
Open $14.18    52 Week Low $1.24 
Day High $14.40    P/E N/A 
Day Low $13.85    EPS $0.00 
Volume 59,621